当前位置：公众访问 >页面
简体中文 / English
1.Screening
1.1.Management for Progress
1.1.1.1.1.1、Character of name

LX

1.1.1.1.1.2、test number

53

1.1.1.1.1.3、Entering time

2019/11/06 (YYYY/MM/DD)

1.2.Inclusion Criteria

aspirin related small intestinal mucosal injury
/
agree with the research plan
/
sign the informed consent
1.3.Exclusion Criteria

contradications of MCCE
/
GI tract obstruction,or pregnant woman,or abdominal operation history, or can not undertake abdominal operation
/
taking drugs that influencing the test during the past one month
/
taking other antiplatelet or anticoagulant drugs
/
GI tumor or IBD diagnosed by MCCE
/
allergy to aspirin, lactobacillus, PEG,or high polymer material
2.Baseline
2.1.Management of the progress
2.2.General information
2.2.2.2.2.1、Basic information

2.2.2.2.2.2、Past history

高血压、高脂血症

2.2.2.2.2.3、GSRS

1

2.3.First result of MCCE
2.2.3.2.3.1、Gastric injury Lanza score

4

2.2.3.2.3.2、Time of gastric examination

20 min

2.2.3.2.3.3、Other result of stomach

无

2.2.3.2.3.4、Small intestine injury score

4

2.2.3.2.3.5、Time of small intestine examination

180 min

2.2.3.2.3.6、Other result of small intestine

空肠溃疡

2.2.3.2.3.7、Whether or not to complete the smll intestine test

yes
2.2.3.2.3.8、Time of passing out the capsule

hour

2.2.3.2.3.9、Side effect of bowel preparation

无

2.2.3.2.3.10、Side effect of MCCE

无

2.4.Result of blood tests
2.2.4.2.4.1、Inflammatory cytokines

2.2.4.2.4.2、Others

2.5.Result of stool microbiota test
2.2.5.2.5.1、Phylum level

Actinobacteria 9.7 Ascomycota 0 Bacteroidetes 52.32 Euryarchaeota 0 Firmicutes 33.21 Fusobacteria 0 Proteobacteria 4.78 Synergistetes 0 Verrucomicrobia 0 Viruses_noname 0 others 0

2.2.5.2.5.2、Class level

Actinobacteria 9.9 Bacilli 0.38 Bacteroidia 47.84 Betaproteobacteria 1.69 Clostridia 35 Deltaproteobacteria 1.28 Erysipelotrichia 0.03 Gammaproteobacteria 2.6 Negativicutes 1.27 Verrucomicrobiae 0 others 0

2.2.5.2.5.3、Order level

Bacteroidales 48.11 Bifidobacteriales 5.11 Burkholderiales 2.23 Clostridiales 38.29 Coriobacteriales 0.76 Desulfovibrionales 1.06 Enterobacteriales 2.77 Lactobacillales 0.28 Selenomonadales 1.28 Verrucomicrobiales 0 others 0.11

2.2.5.2.5.4、Family level

Bacteroidaceae 50.66 Bifidobacteriaceae 4.26 Enterobacteriaceae 2.3 Eubacteriaceae 8.87 Lachnospiraceae 9.2 Porphyromonadaceae 3.62 Prevotellaceae 0.01 Rikenellaceae 0.28 Ruminococcaceae 15.37 Veillonellaceae 1.21 others 4.23

2.2.5.2.5.5、Genus level

Alistipes 0.27 Bacteroides 49.3 Bifidobacterium 4.89 Escherichia 2.62 Eubacterium 9.6 Faecalibacterium 8.54 Parabacteroides 4.29 Prevotella 0.01 Roseburia 6.23 Subdoligranulum 0.5 others 13.75

2.2.5.2.5.6、Specie level

Bacteroides_coprocola 0.01 Bacteroides_dorei 0 Bacteroides_ovatus 3.51 Bacteroides_plebeius 0.02 Bacteroides_stercoris 0.01 Bacteroides_vulgatus 20.87 Escherichia_coli 2.07 Eubacterium_rectale 7.35 Faecalibacterium_prausnitzii 8.49 Prevotella_copri 0.01 others 57.67

2.2.5.2.5.7、Functional gene

2.2.5.2.5.8、Functional pathway

2.2.5.2.5.9、Data of stool microbiata

2.6.Others

3.In the process of the treatment
3.1.Whether or not to enter the test and group

Lactobacillus group
3.2.Primary symptom

3.3.Using other drugs

3.4.Side effect

无

3.5.Others

4.At the end of the treatment
4.1.Whether or not to exit

Complete the research
4.2.GSRS after treatmrnt

4.3.Sceond result of MCCE
4.4.3.4.3.1、Gastric injury Lanza score

2

4.4.3.4.3.2、Time of gastric examination

20 min

4.4.3.4.3.3、Other result of stomach

4.4.3.4.3.4、Small intestine injury score

2

4.4.3.4.3.5、Time of small intestine examination

480 min

4.4.3.4.3.6、Other result of small intestine

无

4.4.3.4.3.7、Whether or not to complete the smll intestine test

yes
4.4.3.4.3.8、Time of passing out the capsule

hour

4.4.3.4.3.9、Side effect of bowel preparation
4.4.3.4.3.10、Side effect of MCCE

4.4.Result of blood tests after treatment
4.4.4.4.4.1、Inflammatory cytokines

4.4.4.4.4.2、Others

4.5.Result of stool microbiota test after treatment
4.4.5.4.5.1、Phylum level

Actinobacteria 1.95 Ascomycota 0.13 Bacteroidetes 76.58 Euryarchaeota 0 Firmicutes 1.93 Fusobacteria 0.02 Proteobacteria 19.41 Synergistetes 0 Verrucomicrobia 0 Viruses_noname 0 others 0

4.4.5.4.5.2、Class level

Actinobacteria 2.04 Bacilli 0.12 Bacteroidia 71.88 Betaproteobacteria 0.56 Clostridia 2.04 Deltaproteobacteria 0.26 Erysipelotrichia 0.02 Gammaproteobacteria 23.01 Negativicutes 0 Verrucomicrobiae 0 others 0.06

4.4.5.4.5.3、Order level

Bacteroidales 70.57 Bifidobacteriales 1.11 Burkholderiales 0.72 Clostridiales 2.18 Coriobacteriales 0.04 Desulfovibrionales 0.21 Enterobacteriales 24.99 Lactobacillales 0.09 Selenomonadales 0 Verrucomicrobiales 0 others 0.08

4.4.5.4.5.4、Family level

Bacteroidaceae 59.41 Bifidobacteriaceae 0.91 Enterobacteriaceae 20.53 Eubacteriaceae 0 Lachnospiraceae 0.72 Porphyromonadaceae 16.3 Prevotellaceae 0 Rikenellaceae 0 Ruminococcaceae 1.28 Veillonellaceae 0 others 0.84

4.4.5.4.5.5、Genus level

Alistipes 0 Bacteroides 53.95 Bifidobacterium 0.98 Escherichia 21.64 Eubacterium 0 Faecalibacterium 0.91 Parabacteroides 20.48 Prevotella 0 Roseburia 0.02 Subdoligranulum 0.07 others 1.95

4.4.5.4.5.6、Specie level

Bacteroides_coprocola 0 Bacteroides_dorei 0.01 Bacteroides_ovatus 0.39 Bacteroides_plebeius 0.03 Bacteroides_stercoris 0 Bacteroides_vulgatus 26.45 Escherichia_coli 19.56 Eubacterium_rectale 0 Faecalibacterium_prausnitzii 0.93 Prevotella_copri 0 others 52.64

4.4.5.4.5.7、Functional gene

4.4.5.4.5.8、Functional pathway

4.4.5.4.5.9、Data of stool microbiata

4.6.Others after treatment

5.Logging data
5.1.Keyboarder

孙亚梅

5.2.Time of logging

2020/07/30 (YYYY/MM/DD)

6.Speciman management system
7.Data management system
8.ADR/ADE management system
9.Madicine management system
10.Research team
10.1.Researchers
11.Design, Methods
11.1.Calculation of sample size

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有